SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 795,500 shares, a growth of 411.9% from the December 15th total of 155,400 shares. Approximately 7.7% of the company’s shares are sold short. Based on an average trading volume of 7,930,000 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SciSparc stock. Renaissance Technologies LLC acquired a new stake in SciSparc Ltd. (NASDAQ:SPRC) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned approximately 5.59% of SciSparc at the end of the most recent quarter. 25.06% of the stock is owned by institutional investors.

SciSparc Trading Down 9.3 %

Shares of NASDAQ SPRC traded down $0.08 during mid-day trading on Tuesday, reaching $0.78. 646,281 shares of the company’s stock were exchanged, compared to its average volume of 28,410,832. SciSparc has a twelve month low of $0.20 and a twelve month high of $6.78. The business has a fifty day simple moving average of $0.34 and a 200 day simple moving average of $0.37.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.